Therapeutics and Targets: Identification, Validation, and Markers

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 41-50 of 90 total displayed.

Past content

CCR Focus
Nuclear Imaging Probes: from Bench to Bedside

Hans-Jürgen Wester
Clin. Cancer Res. 2007; 13: 3470-3481. [Abstract] [Full text] [PDF]  

Reviews
Microtubule-Associated Proteins as Targets in Cancer Chemotherapy

Kumar M.R. Bhat and Vijayasaradhi Setaluri
Clin. Cancer Res. 2007; 13: 2849-2854. [Abstract] [Full text] [PDF]  

Reviews
GRP78 Induction in Cancer: Therapeutic and Prognostic Implications

Amy S. Lee
Cancer Res. 2007; 67: 3496-3499. [Abstract] [Full text] [PDF]  

Review
Tumor-stroma interactions in pancreatic ductal adenocarcinoma

Daruka Mahadevan and Daniel D. Von Hoff
Mol. Cancer Ther. 2007; 6: 1186-1197. [Abstract] [Full text] [PDF]  

Reviews
The power and promise of "rewiring" the mitogen-activated protein kinase network in prostate cancer therapeutics

Athanasios G. Papatsoris, Michalis V. Karamouzis, and Athanasios G. Papavassiliou
Mol. Cancer Ther. 2007; 6: 811-819. [Abstract] [Full text] [PDF]  

Reviews
Important Therapeutic Targets in Chronic Myelogenous Leukemia

Hagop M. Kantarjian, Francis Giles, Alfonso Quintás-Cardama, and Jorge Cortes
Clin. Cancer Res. 2007; 13: 1089-1097. [Abstract] [Full text] [PDF]  

Reviews
Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications

Shrikanta Chattopadhyay, Richard G. Moran, and I. David Goldman
Mol. Cancer Ther. 2007; 6: 404-417. [Abstract] [Full text] [PDF]  

Reviews
Why should we still care about oncogenes?

Kathleen M. Diehl, Evan T. Keller, and Kathleen M. Woods Ignatoski
Mol. Cancer Ther. 2007; 6: 418-427. [Abstract] [Full text] [PDF]  

Drug Development Series: Review
Disrupting insulin-like growth factor signaling as a potential cancer therapy

Deepali Sachdev and Douglas Yee
Mol. Cancer Ther. 2007; 6: 1-12. [Abstract] [Full text] [PDF]  

Reviews
Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy

Hong Chang and Aaron D. Schimmer
Mol. Cancer Ther. 2007; 6: 24-30. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9